"The "problem" here is that no one knows how Vascepa works."
In fairness, one could say the same of apabetalone. Both Vascepa and Apabetalone affect multiple cardioprotective pathways. Which one(s) are the pathways responsible for the MACE reduction for Vascepa or apabetalone?
BearDownAZ